Coregreen Biosciences Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
as on 17-12-2024
- Paid Up Capital ₹ 0.10 M
as on 17-12-2024
- Company Age 20 Year, 17 Days
- Last Filing with ROC 31 Mar 2023
- Revenue %
(FY 2023)
- Profit 27.55%
(FY 2023)
- Ebitda -223.93%
(FY 2023)
- Net Worth -3.63%
(FY 2023)
- Total Assets 52940.59%
(FY 2023)
About Coregreen Biosciences
The Corporate was formerly known as Vallo Software Private Limited. The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Rama Sreeramaneni, Srinivas Sreeramaneni, and Vamsi Vemula serve as directors at the Company.
- CIN/LLPIN
U40300TG2004PTC044750
- Company No.
044750
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
02 Dec 2004
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Coregreen Biosciences?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rama Sreeramaneni  | Director | 10-Jan-2011 | Current |
| Srinivas Sreeramaneni | Director | 02-Dec-2004 | Current |
| Vamsi Vemula | Director | 10-Mar-2014 | Current |
Financial Performance and Corporate Structure Insights of Coregreen Biosciences.
Coregreen Biosciences Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 27.55% increase in profit. The company's net worth dipped by a decrease of 3.63%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Coregreen Biosciences?
Unlock access to Coregreen Biosciences's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Core Green Sugar And Fuels Private LimitedActive 19 years 5 monthsSrinivas Sreeramaneni and Vamsi Vemula are mutual person
- Cg Agro Enterprises & Traders Private LimitedActive 15 years 9 months
Srinivas Sreeramaneni is a mutual person
Ramas Enterprises LlpActive 1 year 1 monthRama Sreeramaneni and Srinivas Sreeramaneni are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Coregreen Biosciences?
Unlock and access historical data on people associated with Coregreen Biosciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Coregreen Biosciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Coregreen Biosciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
